Answers are grounded in this paper and cite their sources.
Short-chain fatty acids (SCFAs) produced by gut microbiota are key modulators of intestinal homeostasis and immune responses. Although their anti-inflammatory roles are well established, the mechanisms by which SCFAs-FFAR2 shapes neutrophil function and influences intestinal inflammation remain unclear. Here, we demonstrate that dietary fiber or acetate protect mice from DSS-induced colitis despite increasing neutrophil infiltration into the intestinal tissue. Importantly, neutrophils are required for the protective effects of acetate, which are also dependent on FFAR2 signaling and IL-22. Neutrophil-specific deletion of FFAR2 impairs IL-22 responses, increases epithelial damage, and exacerbates colitis, while administration of recombinant IL-22 is sufficient to restore acetate protection in this context. Analysis of human ulcerative colitis biopsies reveals increased FFAR2 + neutrophils correlating with IL-22-related gene signatures. These findings indicate that acetate–FFAR2–neutrophil–IL-22 axis modulates intestinal inflammation, revealing a metabolic mechanism that links microbiota-derived signals to mucosal protection and highlighting potential therapeutic targets for inflammatory bowel diseases.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: